CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the use of risperidone, a second-generation antipsychotic, in children and adolescents with conduct disorder and schizophrenia. It aims to conduct clinical studies to gather data on efficacy and safety, ultimately seeking regulatory approval for pediatric use and sharing findings with healthca…
Second-generation antipsychotics are increasingly being prescribed to children and adolescents.
Their use, however, is mostly off-label, and adequate and sufficient data about efficacy and particular safety are lacking.
This proposal focuses on two indications, the use of risperidone in children and adolescents with conduct disorder who are not mentally retarded, and the use of risperidone in adolescents with schizophrenia.
The objectives are to 1) perform a series of clinical studies that will…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
UNIVERSITAIR MEDISCH CENTRUM GRONINGEN
Netherlands, Groningen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT
Germany, Mannheim
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Dundee
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
